REGENXBIO Inc.RGNXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
5Y CAGR+9.1%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+9.1%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
202530.92%
202412.97%
2023-2.00%
2022-264.32%
2021234.17%
202019.98%
2019-269.12%
2018216.10%
2017-16.14%
2016-182.40%